Funding
Active Funding
National Cancer Institute, NIH – R01 [R01CA258682]
Title: Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
Role - Co-I (PI: Dayanidhi)
National Cancer Institute, NIH-R21 [1R21CA256462-01A1]
Title: Targeting eIF4A along with immunotherapy to overcome chemoresistance;
Role: Co-I (PI: Dayanidhi)
Scleroderma Foundation
Title: The development of TRPM8 targeted therapy against Raynaud’s phenomenon Disease States;
Role: Co-I (PI: Ding)
Ohio State Dept of Higher Education (ODHE)
Title: Health Effects of Dermal Contact to Cyanotoxins in At-Risk Preexisting Disease States;
Role - Co-I
Department of Defense, BCRP Level 2 [W81XWH2110053]
Title: Development of Novel Inducers of Nonapoptotic Cell Death to Target TNBC;
Role: PI
Susan G. Komen CCR Award [CCR18548498]
Title: Necroptosis induction to target triple negative breast cancer
Role: PI
National Science Foundation – MRI Grant [Award#1919337]
Title: MRI: Acquisition of a Transmission Electron Microscope for Research and Training.;
Role: Co-PI
TSWREIS - Telangana Social Welfare Residential Educational Institutions Society Educational
Funds
Title: Indo-US STEM Outreach Program for Underserved Students
Role - PI
UT-AYRP undergraduate research award
Title: Developing thienopyrimidines analogs against chemo-resistant tumors.
Role - Mentor (PI: Dusseau, N)
T32-G-RISE NIH-NIGMS
Title: Training in Translational and Molecular Cell Dynamics (TMCD).
Role – Consultant (PI: Osman)
Research Awards and Fellowships URFO Program
Title: A High Throughput Biomimetic Microfluidic Platform for Recapitulating Breast Cancer
Metastasis
Role – Co-I (PI: Tang)
IRIA – Interdisciplinary Research Initiative Award
Title: Role of formins in therapy resistance in glioblastoma patient cell lines
Role – Co-PI (PI: Eissenman)
Research Innovation Award – UT-ORSP
Title: ABC transporters as targets for drugs of abuse
Role – PI
Undergraduate Summer Research and Creative Activity Program
Title: Development of novel topoisomerase II alpha inhibitors against colorectal cancer
Role - Mentor (PI: Dusseau, N)
Completed
Systems Oncology, LLC -licensed our technology on methuophagy (05/18 to 06/20)
Title: Novel anticancer technologies
Role: PI
Systems Oncology, LLC -sponsored research agreement (08/18 to 10/19)
Title: Development of Patentable, Methuophagy Inducing Compounds for Cancer Therapy
Role: PI; (MPI: Erhardt)
Dearce-Koch Memorial Endowment Fund Award (06/18 to 05/19)
Title: Methuophagy induction to target apoptosis resistance
Role: PI
The Paso Del Norte Health Foundation (03/18 to 08/19)
Title: In vivo Characterization of Nicotine Loaded Solid Lipid Nanoparticle Hydrogels;
Role: Co-I; (PI: Boddu)
STAR OUR-UT Undergraduate research award (05/18 to 08/18)
Title: Developing thienopyrimidines analogs against chemo-resistant tumors.
Role - Mentor (PI:Mell, K)
Union International Cancer Control (12/17 to 02/18)
Title: Use of CRISPR technology for mammalian genome engineering and generation of eukaryotic
cell lines for studying apoptosis in cancer cells
Role: Mentor; (PI: Seth)
Woods Hole Pilot Grant (11/17 to 03/19)
Title: Alkenones toxicity and applications
Role: PI
California Grape Commission (08/14 to 07/15)
Title: Effects of Whole Grape Powder on NF-kB driven inflammatory signaling
Role: Co-PI; (PI:Samuel)
U54: Morehouse School of Medicine/Tuskegee University/ Univ. Of Alabama at Birmingham
Comprehensive Cancer Center; Partnership– pre-pilot projects
Title: The role of TTP-Lin28-let-7-axis in the regulation of colorectal cancer treatment;
Role: PI; (MPI/Co-Lead PI: Esther)
UAB MHRC- Health Disparities Research Training Program Grant (02/14 to 02/15)
Title: Role of ABCC family of transporters and their signaling pathway in the regulation
of chemotherapy responses in pancreatic cancers;
Role: PI
Ray-Biotech –Pilot-Biomarker grants (03/10 to 02/13)
Title: Identify biomarkers of resistance or response to anti-EGFR therapy of cancers
Role: Co-PI; (PI: Chen)